The George Clinical Statistics team has extensive experience in the design and analysis of clinical trials, including adaptive designs. Our Statistics Team are familiar with a wide range of therapeutic areas, including, but not limited to: Oncology, Medical Devices, Cardiology; Neurology, Respiratory, Renal, Endocrinology, Pain Control, Infectious Diseases, Critical Care, Substance Abuse.
This includes complex clinical trials using cluster, cluster-crossover, and stepped-wedged designs. The statistical team also supports a range of other research projects (complex surveys longitudinal studies, risk score development.) and provides general advice and training. The team has the capacity to execute an innovative statistical research program aimed at addressing methodological problems relevant to our medical research.
We support clinical trials and other research projects from conception to publication. All the analyses use up-to-date and validated software (eg. SAS and Stata for statistical analyses, PASS for sample size calculations) and are performed to ICH GCP standards with emphasis on validation, traceability and reproducibility.
Our Statistics experts deliver:
- Study design and protocol review
- Sample size and power calculations
- Statistical analysis plan
- Data Safety Monitoring Board (DSMB) support
- Interim analyses
- Statistical programming and validation
- Reports and scientific publications
Our Statistics team operate globally and have unique expertise in Australia China, India, Japan, Korea, Hong Kong, New Zealand, and Malaysia.
Our Statistics experts analyse and design clinical trials across a broad range of therapeutic areas.
To see the breadth of our networks in each therapeutic area, please click below links: